341
Participants
Start Date
December 31, 2015
Primary Completion Date
February 28, 2018
Study Completion Date
April 30, 2018
QPI-1002
IV injection
Placebo
isotonic saline
Columbia University, New York
Charité - Universitätsmedizin Berlin, Berlin
Suburban Hospital, Bethesda
Johns Hopkins University, Baltimore
Duke University, Durham
Jacksonville Center for Clinical Research, Jacksonville
River City Clinical Research, Jacksonville
University of Florida, Gainesville
Universitätsklinikum Giessen und Marburg / Standort Giessen / Zentrum für Chirurgie, Giessen
Ohio State University Medical Center, Columbus
Cleveland Clinic Foundation, Cleveland
Westdeutsches Herzzentrum Essen / Universitätsklinikum Essen, Essen
Lindner Research Center, The Christ Hospital, Cincinnati
St. Vincent Medical Group, Indianapolis
Indiana Ohio Heart, Fort Wayne
Mid Michigan Cardiovascular Research, Midland
Cardiac & Vascular Research Center of Northern Michigan, Petoskey
Klinikum der Universität zu Köln, Cologne
Aurora St. Luke's Medical Center, Milwaukee
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Advocate Christ Medical Center, Oak Lawn
Washington University, St Louis
Bryan Heart, Lincoln
Universitätsklinikum Heidelberg, Heidelberg
Baylor University, Dallas
University of Arizona Sarver Heart Center, Tucson
St. John Regional Hospital, Saint John
Hamilton Health Sciences, Hamilton
University of Ottawa Heart Institute, Ottawa
St. Michael's Hospital, Toronto
Centre hospitalier de l'universite de Montreal, Montreal
Mcgill University Health Center - Royal Victoria Hospital, Montreal
Montreal Heart Institute, Montreal
Instiut Universitaire de Cardiologie et Pneumologie de Quebec, Québec
Herzzentrum Dresden GmbH, Dresden
Herzzentrum Leipzig GmbH, Leipzig
Lead Sponsor
Quark Pharmaceuticals
INDUSTRY